Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma 3Solid Tumor 2Mesothelioma, Malignant 2Uveal Melanoma 1Solid Tumor, Adult 1Recurrence 1MMR-D/MSI-H Colorectal Cancers 1Lung Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1Advanced Solid Tumor, Adult 1Advanced Solid Tumor 1

Interventions

Injections 27Carboplatin 18Docetaxel 14pembrolizumab 13Paclitaxel 12Bevacizumab 10durvalumab 8Nivolumab 8Cisplatin 8Fluorouracil 7Pemetrexed 6Oxaliplatin 6Leucovorin 6trifluridine tipiracil drug combination 5toripalimab 5tislelizumab 5linifanib 5Capecitabine 5zimberelimab 4talazoparib 4olaparib 4fludarabine 4Panobinostat 4Itraconazole 4Irinotecan 4Gemcitabine 4Everolimus 4tremelimumab 3sotorasib 3sintilimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × niraparib × Other solid neoplasm × Clear all
NCT03497429 2021-11-09

A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors

Takeda

Phase 1 Completed
9 enrolled 24 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡